Jill M. Quigley - 04 Nov 2025 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Reporting relationship: Director
Issuer ticker: TERN
Reported as of: 04 Nov 2025
Net transaction value: -$214,795
SEC form: 4
Accepted by SEC: 05 Nov 2025, 18:17:46 UTC
Prior SEC filing: 12 Jun 2025
Next SEC filing: 02 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ David Strauss, as Attorney-in-Fact for Jill M. Quigley

Key filing fact

Jill M. Quigley filed Form 4 for Terns Pharmaceuticals, Inc. (TERN) on 05 Nov 2025.

Key facts

This page summarizes Jill M. Quigley's Form 4 filing for Terns Pharmaceuticals, Inc. (TERN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Nov 2025, 18:17.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: -$214,795.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001799780 Primary reporting owner

Quigley Jill M.

Relationship: Director
Address: C/O TERNS PHARMACEUTICALS, INC., 1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Signature: /s/ David Strauss, as Attorney-in-Fact for Jill M. Quigley
Signature date: 05 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TERN transaction

Common Stock

Options Exercise

Transaction value: $226,565
Shares: +24,520
Change %
Price: $9.24
Shares after: 24,520
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1

TERN transaction

Common Stock

Sale

Transaction value: $441,360
Shares: -24,520
Change %: -100%
Price: $18.00
Shares after: 0
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TERN transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -24,520
Change %: -86%
Price: $0.000000
Shares after: 3,955
Date: 04 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,520
Exercise price: $9.24
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.

Footnote F2

1/3rd of the shares subject to the option vested on the first anniversary measured from December 29, 2020 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vested monthly thereafter, such that 100% of the shares subject to the option were fully vested and exercisable on the third anniversary of the Vesting Commencement Date.